Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Wounds and Injuries 1Peripheral Nervous System Diseases 1Pain 1Neuralgia 1Neoplasms 1Lymphoma, Follicular 1HIV Infections 1Bronchiolitis Obliterans Syndrome 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

Doxorubicin 18Vincristine 15Zidovudine 11Bleomycin 11Cyclophosphamide 9Etoposide 8Interferon alpha-2 6Prednisone 5Cytarabine 5tecogalan 4sargramostim 4Rituximab 4Polymerase Chain Reaction 4Liposomes 4Filgrastim 4Dexamethasone 4Methotrexate 3Leucovorin 3Fluorouracil 3interferon alfa-n1 2Watchful Waiting 2Vinblastine 2Tumor Necrosis Factor-alpha 2Thalidomide 2Semaxinib 2Ritonavir 2Peripheral Blood Stem Cell Transplantation 2Mitoxantrone 2Light Coagulation 2Isotretinoin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × HIV Infections × ziconotide × Clear all
NCT00002160 2005-06-24

A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain

NIH AIDS Clinical Trials Information Service

Phase 2 Completed
100 enrolled

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Neoplasms, Pain, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡